N Engl J Med · 2011
Abiraterone and increased survival in metastatic prostate cancer
de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, Chi KN, Jones RJ, Goodman OB, Saad F, Staffurth JN, Mainwaring P, Harland S, Flaig TW, Hutson TE, Cheng T, Patterson H, Hainsworth JD, Ryan CJ, Sternberg CN, Ellard SL, Fléchon A, Saleh M, Scholz M, Efstathiou E, Zivi A, Bianchini D, Loriot Y, Chieffo N, Kheoh T, Haqq CM, Scher HI, COU-AA-301 Investigators.
Show affiliations
- de Bono JS — Institute of Cancer Research and Royal Marsden Hospital, Sutton, Surrey, United Kingdom. johann.de-bono@icr.ac.uk
18 read2 want to readRigor 2.6Novelty 2.9Impact 2.4Reprod. 3.0
Most-cited papers citing this
- Lancet · 2026 · cited by 22
- Clin Cancer Res · 2026 · cited by 17
- Ann Oncol · 2026 · cited by 7
- Nat Commun · 2025 · cited by 4
- Endocrinology · 2026 · cited by 3
Log in to like, log, and share thoughts on this paper.
Discussion
Share your thoughts above to start a thread. Constructive feedback only — reply to and like others’ posts.
0
0
0
0
0
0